Next Science Limited
Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial wound Gel; acne gel; oral rinse; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides woun… Read more
Market Cap & Net Worth: Next Science Limited (NXSCF)
Next Science Limited (PINK:NXSCF) has a market capitalization of $14.63 Million ($14.63 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #31025 globally and #10216 in its home market, demonstrating a -28.57% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Next Science Limited's stock price $0.05 by its total outstanding shares 292625365 (292.63 Million).
Next Science Limited Market Cap History: 2019 to 2025
Next Science Limited's market capitalization history from 2019 to 2025. Data shows change from $374.56 Million to $14.63 Million (-44.51% CAGR).
Next Science Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Next Science Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.28x
Next Science Limited's market cap is 1.28 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $374.56 Million | $4.11 Million | -$14.52 Million | 91.14x | N/A |
| 2020 | $292.63 Million | $3.44 Million | -$13.35 Million | 85.04x | N/A |
| 2021 | $263.36 Million | $8.95 Million | -$9.03 Million | 29.43x | N/A |
| 2022 | $123.49 Million | $11.71 Million | -$18.30 Million | 10.54x | N/A |
| 2023 | $61.45 Million | $22.18 Million | -$24.51 Million | 2.77x | N/A |
| 2024 | $29.26 Million | $22.82 Million | -$10.59 Million | 1.28x | N/A |
Competitor Companies of NXSCF by Market Capitalization
Companies near Next Science Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Next Science Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Next Science Limited Historical Marketcap From 2019 to 2025
Between 2019 and today, Next Science Limited's market cap moved from $374.56 Million to $ 14.63 Million, with a yearly change of -44.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $14.63 Million | -50.00% |
| 2024 | $29.26 Million | -52.38% |
| 2023 | $61.45 Million | -50.24% |
| 2022 | $123.49 Million | -53.11% |
| 2021 | $263.36 Million | -10.00% |
| 2020 | $292.63 Million | -21.88% |
| 2019 | $374.56 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Next Science Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.63 Million USD |
| MoneyControl | $14.63 Million USD |
| MarketWatch | $14.63 Million USD |
| marketcap.company | $14.63 Million USD |
| Reuters | $14.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.